Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.
BörsenkürzelSRTS
Name des UnternehmensSensus Healthcare Inc
IPO-datumJun 03, 2016
CEOMr. Joseph C. Sardano
Anzahl der mitarbeiter35
WertpapierartOrdinary Share
GeschäftsjahresendeJun 03
Addresse851 Broken Sound Pkwy NW Ste 215
StadtBOCA RATON
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl33487-3635
Telefon15619225808
Websitehttps://sensushealthcare.com/
BörsenkürzelSRTS
IPO-datumJun 03, 2016
CEOMr. Joseph C. Sardano
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten